Nyumbani › Tumori ya Wilms
Majaribio ya kliniki ya Tumori ya Wilms yanayovutia washiriki nchini Marekani
Masomo 17 ya Tumori ya Wilms yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Washington, DCUtafiti 7
- Memphis, TNUtafiti 6
- Atlanta, GAUtafiti 5
- St. Louis, MOUtafiti 4
- Greenburgh, NYUtafiti 4
- Chicago, ILUtafiti 4
- Cincinnati, OHUtafiti 4
- Mountain View, CAUtafiti 4
- New York City, NYUtafiti 4
- Boston, MAUtafiti 4
- Los Angeles, CAUtafiti 4
- Houston, TXUtafiti 4
- Philadelphia, PAUtafiti 4
- Minneapolis, MNUtafiti 4
- Aurora, COUtafiti 4
- Ann Arbor, MIUtafiti 3
- Birmingham, ALUtafiti 3
Kwa jimbo
- AlabamaUtafiti 3
- CaliforniaUtafiti 5
- ColoradoUtafiti 4
- FloridaUtafiti 3
- GeorgiaUtafiti 5
- IllinoisUtafiti 4
- MassachusettsUtafiti 4
- MichiganUtafiti 3
- MinnesotaUtafiti 5
- MissouriUtafiti 4
- New YorkUtafiti 6
- OhioUtafiti 5
- PennsylvaniaUtafiti 4
- TennesseeUtafiti 6
- TexasUtafiti 6
- Wilaya ya ColumbiaUtafiti 7
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
InaajiriHatua 2
Umri 12 hadi 39 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT04616560Biomarkers of Resiliency In Childhood Cancer Surgery
InaajiriUtafiti wa uchunguzi
Umri 3 hadi 25 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT06674811A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
InaajiriHatua 2
Hadi umri 30 · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT04322318Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
InaajiriHatua 1/2
12 Months – 30 Years · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT04851119Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
InaajiriHatua 1
Umri 1 hadi 23 · Jinsia zote · Imesasishwa 13 Ago 2026 · NCT07172958Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
InaajiriHatua 1
Umri 1 hadi 21 · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT04715191Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
InaajiriHatua 1/2
6 Months – 25 Years · Jinsia zote · Imesasishwa 30 Jun 2026 · NCT06625190B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
InaajiriHatua 1
Hadi umri 21 · Jinsia zote · Imesasishwa 19 Mei 2026 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
InaajiriHatua 1/2
12 Months – 30 Years · Jinsia zote · Imesasishwa 19 Mei 2026 · NCT04901702A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
InaajiriHatua 2
12 Months · Jinsia zote · Imesasishwa 6 Mei 2026 · NCT05985161Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation
InaajiriHatua 2
Umri wote · Jinsia zote · Imesasishwa 23 Apr 2026 · NCT04968990Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
InaajiriHatua 1
Umri 1 hadi 30 · Jinsia zote · Imesasishwa 15 Apr 2026 · NCT04308330Pencil Beam Scanning in Patients With Renal Tumors
InaajiriHatua ya kwanza ya awali
Umri 0 hadi 30 · Jinsia zote · Imesasishwa 15 Apr 2026 · NCT03810651Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
InaajiriHatua 1
Umri 1 hadi 26 · Jinsia zote · Imesasishwa 17 Feb 2026 · NCT07148050Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
InaajiriHatua 1
Hadi umri 21 · Jinsia zote · Imesasishwa 3 Nov 2025 · NCT06198296A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
InaajiriHatua 2
18 Months – 40 Years · Jinsia zote · Imesasishwa 12 Ago 2025 · NCT05135975International PPB/DICER1 Registry
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
0 Minutes – 100 Years · Jinsia zote · Imesasishwa 30 Jan 2025 · NCT03382158Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.